EDARADD anticorps (N-Term)
-
- Antigène Voir toutes EDARADD Anticorps
- EDARADD (EDAR-Associated Death Domain (EDARADD))
-
Épitope
- N-Term
- Reactivité
- Souris, Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EDARADD est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity purification
- Immunogène
- N-terminal region of human EDARADD
- Top Product
- Discover our top product EDARADD Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- 0.01 % Sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
- Antigène
- EDARADD (EDAR-Associated Death Domain (EDARADD))
- Autre désignation
- EDARADD (EDARADD Produits)
- Synonymes
- anticorps 1810032E07Rik, anticorps 5830469M23Rik, anticorps A630043P06, anticorps cr, anticorps ECTD11A, anticorps ECTD11B, anticorps ED3, anticorps EDA3, anticorps EDAR (ectodysplasin-A receptor)-associated death domain, anticorps EDAR associated death domain, anticorps Edaradd, anticorps EDARADD
- Poids moléculaire
- 25 kDa
- UniProt
- Q8WWZ3
- Pathways
- Ubiquitin Proteasome Pathway
-